Status:
COMPLETED
the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children
Lead Sponsor:
Sangjin Park
Conditions:
Respiratory Complication
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
This research attempts to find the optimum dose of remifentanil that can prevent the unnecessary responses such as coughing, gagging, and movement when LMA is inserted during sevoflurane induction in ...
Detailed Description
Anaesthesia is induced by inhalation with 3% sevoflurane. A predetermined bolus dose of remifentanil is injected over 30 seconds. The LMA is attempted 60 seconds after bolus administration. The starti...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists physical status 1 or 2
- undergoing short elective surgery(i.e Strabismus surgery, Entropion surgery, Inguinal hernia surgery, etc) under general anesthesia
Exclusion
- suspected difficult airways
- respiratory disease (chronic obstructive pulmonary disease, upper respiratory infection)
- body mass index \> 30 kg/m2
- allergies to the study drugs
- a history of gastric reflux
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01919203
Start Date
August 1 2013
End Date
July 1 2015
Last Update
July 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine, Yeungnam University hospital
Nam Gu, Daegu, South Korea, 705-035